Programa de Pós-Graduação em Ciências Farmacêuticas/UNIVALI, Rua Uruguai 458, Centro, CEP 88302-202 Itajaí, SC, Brazil.
Programa de Pós-Graduação em Ciências Farmacêuticas/UNIVALI, Rua Uruguai 458, Centro, CEP 88302-202 Itajaí, SC, Brazil.
Behav Brain Res. 2020 Jul 1;389:112601. doi: 10.1016/j.bbr.2020.112601. Epub 2020 Apr 30.
Major Depressive Disorder (MDD) is a highly disabling condition and has been linked to increased inflammatory mediators. Hydroalcoholic extract from barks of Rapanea ferruginea (HEBRF) and the majoritary compounds-myrsinoic acid A (MAA) and B (MAB)-have been studied due to their anti-inflammatory potential, but there is no evidence about its antidepressant-like effects. This research investigated the HEBRF, MAA, and MAB antidepressant-like effect, besides the involvement of the monoaminergic system and MAO-A activity in the HEBRF antidepressant-like effect. HEBRF (50-300 mg/kg, p.o.), MAA (5-30 mg/kg, p.o.) or MAB (3-60 mg/kg, p.o.) were administrated to mice, and behavioral parameters were assessed using the tail suspension test (TST), splash test (ST) and open field test (OFT). The involvement of monoaminergic system in the HEBRF antidepressant-like effect was established through the pretreatment of mice with antagonists. The influence triggered by HEBRF in the monoamine oxidase A (MAO-A) activity was evaluated in the hippocampus (HIP) and prefrontal cortex (PFC) of mice. HEBRF (100-300 mg/kg) promoted antidepressant-like effect in the TST and augmented the total time of grooming in the ST, without compromising the locomotor activity. Pretreatment of mice with serotoninergic, dopaminergic, and noradrenergic antagonists, reversed the HEBRF antidepressant-like effect. Besides, HEBRF inhibited the MAO-A activity in the HIP and PFC. Moreover, MAA (5 mg/kg) and MAB (3 mg/kg) also promoted antidepressant-like and anti-anhedonic effects in mice. Data showed that monoaminergic system is involved in the HEBRF antidepressant-like effect, besides MAA and MAB possibly could be responsible for these pharmacological effects.
重度抑郁症(MDD)是一种高度致残的疾病,与炎症介质的增加有关。由于具有抗炎潜力,人们研究了拉帕内亚·费鲁吉内亚(Rapanea ferruginea)树皮的水醇提取物(HEBRF)和主要化合物-迷迭香酸 A(MAA)和 B(MAB),但尚无关于其抗抑郁作用的证据。本研究调查了 HEBRF、MAA 和 MAB 的抗抑郁样作用,以及单胺能系统和 MAO-A 活性在 HEBRF 抗抑郁样作用中的参与。通过灌胃给予小鼠 HEBRF(50-300mg/kg)、MAA(5-30mg/kg)或 MAB(3-60mg/kg),并使用悬尾试验(TST)、泼溅试验(ST)和旷场试验(OFT)评估行为参数。通过用拮抗剂预处理小鼠,确定单胺能系统在 HEBRF 抗抑郁样作用中的参与。通过评估 HEBRF 对小鼠海马(HIP)和前额叶皮层(PFC)中单胺氧化酶 A(MAO-A)活性的影响,研究了 HEBRF 对 MAO-A 活性的影响。HEBRF(100-300mg/kg)在 TST 中促进抗抑郁样作用,并增加 ST 中的总梳理时间,而不影响运动活性。用 5-羟色胺能、多巴胺能和去甲肾上腺素能拮抗剂预处理小鼠,逆转了 HEBRF 的抗抑郁样作用。此外,HEBRF 抑制了 HIP 和 PFC 中的 MAO-A 活性。此外,MAA(5mg/kg)和 MAB(3mg/kg)也在小鼠中促进了抗抑郁和抗快感缺失作用。数据表明,单胺能系统参与了 HEBRF 的抗抑郁样作用,并且 MAA 和 MAB 可能负责这些药理作用。